Recombinant Francisella tularensis subsp. novicida ATP synthase subunit b (atpF)

What is the role of ATP synthase subunit b (atpF) in F. tularensis biology?

ATP synthase subunit b (atpF) serves as a critical peripheral stalk component of the F₁F₀-ATP synthase complex in Francisella tularensis. This protein anchors the catalytic F₁ portion to the membrane-embedded F₀ sector, maintaining the structural integrity necessary for ATP synthesis. In F. tularensis, the proton gradient across the cytoplasmic membrane drives ATP synthesis via this complex, making atpF essential for energy production and bacterial survival. Unlike many membrane proteins that have been extensively characterized as virulence factors in F. tularensis, atpF primarily functions in bioenergetics but may indirectly influence pathogenesis through its role in cellular metabolism and adaptation to host environments. The protein appears to be conserved across F. tularensis subspecies with high sequence homology, suggesting evolutionary pressure to maintain its structural and functional properties.

How does F. tularensis subsp. novicida differ from other subspecies regarding ATP synthase components?

F. tularensis subsp. novicida represents a less virulent subspecies compared to the highly pathogenic tularensis (Type A) and holarctica (Type B) subspecies, making it valuable for laboratory research as a model organism. Regarding ATP synthase components, genomic analyses reveal that while the core structure of the ATP synthase complex is conserved across subspecies, novicida exhibits subtle sequence variations in the atpF gene. These differences do not appear to fundamentally alter the protein's function but may contribute to metabolic adaptations specific to its environmental niche. Unlike the human pathogenic subspecies that show genome decay and pseudogene formation in various metabolic pathways, novicida maintains a more complete set of genes related to energy metabolism . This genomic stability makes novicida particularly useful for studying fundamental aspects of Francisella energy production without the complications of attenuated metabolic pathways found in the more virulent subspecies.

Why do researchers use recombinant expression systems for studying F. tularensis atpF?

Researchers employ recombinant expression systems for studying F. tularensis atpF for several practical and scientific reasons. First, F. tularensis is a CDC Category A bioterrorism agent requiring BSL-3 containment facilities, making direct work with the pathogen challenging and restricted. Recombinant expression in surrogate hosts like E. coli allows for protein production in BSL-1/BSL-2 settings. Second, the naturally low abundance of membrane proteins like atpF in native bacteria makes purification of sufficient quantities for structural and functional studies nearly impossible without overexpression systems. Third, recombinant approaches enable protein engineering including addition of affinity tags for purification, site-directed mutagenesis for structure-function studies, and protein fusion constructs for localization experiments. Additionally, expression in heterologous systems permits isotopic labeling for NMR studies and seleno-methionine incorporation for X-ray crystallography phase determination. These advantages make recombinant expression the preferred methodology despite potential limitations in post-translational modifications or proper membrane insertion.

What are the optimal conditions for recombinant expression of F. tularensis atpF in E. coli?

The optimal conditions for recombinant expression of F. tularensis subsp. novicida atpF in E. coli involve several critical parameters that must be carefully controlled. The most effective expression system typically employs BL21(DE3) or C43(DE3) E. coli strains, with the latter specifically engineered for membrane protein expression. The atpF gene should be codon-optimized for E. coli and cloned into vectors containing moderate-strength promoters such as pET28a or pMAL-c5X rather than strong promoters that may lead to inclusion body formation. Induction parameters significantly impact yield and solubility: expression at lower temperatures (16-20°C) for extended periods (16-24 hours) after induction with reduced IPTG concentrations (0.1-0.3 mM) typically produces better results than standard conditions. The addition of membrane-stabilizing additives such as glycerol (5-10%) to growth media can improve the proper folding of this membrane protein. The incorporation of a cleavable N-terminal tag (His₆ or MBP) rather than C-terminal modifications preserves the natural membrane insertion of the protein. These conditions must be empirically optimized for each expression construct, with small-scale expression trials preceding large-scale production.

How can researchers efficiently purify recombinant F. tularensis atpF while maintaining its native conformation?

Efficient purification of recombinant F. tularensis atpF while preserving its native conformation requires a carefully designed protocol addressing the challenges inherent to membrane protein isolation. The process begins with membrane fraction isolation using differential ultracentrifugation after cell lysis by sonication or French press. Extraction requires screening detergents for optimal solubilization; typically, mild non-ionic detergents like n-dodecyl-β-D-maltoside (DDM) at 1-2% for extraction and 0.02-0.05% for subsequent steps prove most effective. Immobilized metal affinity chromatography (IMAC) using Ni-NTA or TALON resin provides initial purification when using His-tagged constructs, followed by size exclusion chromatography to remove aggregates and ensure monodispersity. Throughout purification, maintenance of a physiologically relevant buffer system (pH 7.2-7.5, 150-300 mM NaCl) with glycerol (5-10%) and appropriate detergent concentrations above the critical micelle concentration is essential for structural integrity. Quality assessment using techniques such as circular dichroism spectroscopy and thermal shift assays should confirm proper folding before proceeding to functional or structural studies. If required for specific applications, detergent exchange or reconstitution into nanodiscs or liposomes can provide a more native-like membrane environment.

What analytical methods are most effective for assessing the structural integrity of purified atpF protein?

Analyzing structural integrity of purified F. tularensis atpF requires complementary biophysical techniques that address different aspects of protein folding and stability. Circular dichroism (CD) spectroscopy provides essential secondary structure information, with properly folded atpF exhibiting characteristic alpha-helical signatures with negative peaks at 208 and 222 nm. Size exclusion chromatography coupled with multi-angle light scattering (SEC-MALS) assesses monodispersity and oligomeric state, critical for confirming proper assembly rather than aggregation. Differential scanning fluorimetry (DSF) or nano-differential scanning calorimetry (nano-DSC) measures thermal stability, providing melting temperatures (Tm) that indicate the protein's conformational stability in various buffer conditions. Limited proteolysis followed by mass spectrometry identifies protected regions consistent with proper folding versus exposed disordered segments. For more detailed structural assessment, negative-stain electron microscopy can visualize individual particles and their distributions. Nuclear magnetic resonance (NMR) spectroscopy using 15N-HSQC fingerprinting can evaluate tertiary structure formation through signal dispersion, even without complete structure determination. When combined, these techniques provide comprehensive verification of structural integrity before proceeding to functional assays or more resource-intensive structural biology methods.

How can researchers effectively assess ATP synthase activity of recombinant atpF in reconstituted systems?

Assessing ATP synthase activity of recombinant atpF requires reconstitution of the complete F₁F₀-ATP synthase complex in a system that permits measurement of proton translocation coupled to ATP synthesis/hydrolysis. The most informative approach combines protein reconstitution into liposomes with functional assays monitoring both ATP synthesis and proton translocation. Researchers should co-reconstitute purified recombinant atpF with other ATP synthase subunits (either individually expressed or as sub-complexes) into liposomes containing the pH-sensitive fluorescent dye ACMA (9-amino-6-chloro-2-methoxyacridine). Activity assessment involves establishing a proton gradient across liposomal membranes using valinomycin and K⁺, then monitoring ATP synthesis rates using a luciferin/luciferase-based luminescence assay. Alternatively, ATP hydrolysis coupled to proton pumping can be measured by tracking ACMA fluorescence quenching. Control experiments must include protonophore (CCCP) addition to collapse the gradient, oligomycin to specifically inhibit ATP synthase, and reconstitution with known inactive atpF mutants. Quantitative analysis should report turnover rates (mol ATP/mol enzyme/time) under standardized conditions. This approach distinguishes between assembly defects and catalytic dysfunction, providing mechanistic insights into how specific atpF modifications affect ATP synthase function.

What experimental approaches can determine whether atpF interacts with other F. tularensis proteins beyond the ATP synthase complex?

Determining atpF interactions beyond the ATP synthase complex requires a multi-faceted approach combining both in vitro and in vivo techniques. In vivo cross-linking using membrane-permeable agents such as formaldehyde or DSP (dithiobis[succinimidyl propionate]) followed by co-immunoprecipitation can capture physiologically relevant interactions directly in F. tularensis cells. For higher throughput screening, bacterial two-hybrid systems specifically adapted for membrane proteins (such as BACTH) can identify binary interactions between atpF and candidate proteins. More comprehensive interaction mapping employs proximity-dependent biotin labeling methods (BioID or APEX) with atpF as the bait protein, followed by streptavidin pulldown and mass spectrometry identification of proximal proteins. For validation of specific interactions, microscale thermophoresis (MST) or surface plasmon resonance (SPR) provides quantitative binding parameters using purified components. Functional validation through co-localization studies using fluorescently tagged proteins and super-resolution microscopy can confirm interactions in the cellular context. Comparative interactome analysis under different growth conditions (e.g., stress, host cell infection) may reveal condition-specific interaction partners that suggest broader functional roles for atpF beyond ATP synthesis, potentially in stress response or virulence mechanisms.

How do mutations in the atpF gene affect F. tularensis growth and virulence in experimental models?

Mutations in the atpF gene significantly impact F. tularensis growth and virulence through disruption of bioenergetic processes essential for bacterial survival and pathogenesis. In experimental models, atpF deletion mutants (ΔatpF) exhibit severe growth defects in nutrient-limited media, indicating compromised energy generation capacity. Complementation studies with wild-type atpF restore normal growth, confirming the phenotype's specificity. In cell culture infection models using macrophages (J774 or primary BMDMs), atpF mutants show impaired intracellular replication, with approximately 2-3 log reduction in bacterial burden by 24 hours post-infection compared to wild-type strains. This defect correlates with reduced ATP levels and diminished ability to escape phagosomal compartments, a critical step in F. tularensis pathogenesis. In murine infection models, atpF mutants demonstrate attenuated virulence with significantly increased LD50 values and reduced bacterial dissemination to liver and spleen. Interestingly, point mutations affecting key functional domains of atpF produce varying phenotypes depending on the specific residues altered, with mutations in membrane-spanning regions generally more detrimental than those in cytoplasmic domains. Site-directed mutagenesis studies reveal that conserved residues mediating interactions with other ATP synthase subunits are particularly critical for both growth and virulence, highlighting the essential role of proper ATP synthase assembly and function in F. tularensis pathogenesis.

How does F. tularensis atpF compare structurally and functionally to homologous proteins in other bacterial pathogens?

F. tularensis atpF exhibits notable structural and functional similarities to homologous proteins in other bacterial pathogens while maintaining distinctive features that reflect its evolutionary adaptations. Sequence alignment analyses reveal approximately 40-60% identity with atpF homologs in other gamma-proteobacteria, with highest conservation in the C-terminal domain that interacts with the F₁ sector of ATP synthase. The membrane-spanning N-terminal domain shows greater sequence divergence, potentially reflecting adaptations to Francisella's unique membrane composition. Structurally, F. tularensis atpF contains two predicted transmembrane helices rather than the single transmembrane segment found in many other bacterial species, suggesting altered membrane anchoring. Functionally, while the core role in ATP synthesis is conserved, complementation experiments demonstrate that F. tularensis atpF cannot fully restore function when expressed in E. coli or other bacterial atpF mutants, indicating species-specific interactions within the ATP synthase complex. Unlike homologs in some bacterial pathogens that have acquired secondary functions in processes such as maintaining membrane potential during stress or contributing to acid resistance, current evidence suggests F. tularensis atpF remains primarily dedicated to its bioenergetic role. These comparisons highlight how a conserved component of cellular energetics has evolved species-specific adaptations that may contribute to Francisella's unique lifestyle as an intracellular pathogen.

What insights can bioinformatic analysis provide about the evolution of atpF across Francisella species and subspecies?

Bioinformatic analysis of atpF across Francisella species and subspecies reveals evolutionary patterns that reflect both functional constraints and adaptations to different ecological niches. Multiple sequence alignments show >90% amino acid sequence identity among F. tularensis subspecies (tularensis, holarctica, and novicida), with most variations occurring in the N-terminal region and transmembrane domains. Phylogenetic analysis indicates that atpF evolution largely parallels whole-genome phylogeny of Francisella species, suggesting vertical inheritance without significant horizontal gene transfer events. Selective pressure analysis using dN/dS ratios demonstrates strong purifying selection (dN/dS < 0.1) on residues involved in interactions with other ATP synthase subunits, particularly those contacting the δ and α subunits, highlighting functional constraints on these regions. Interestingly, several surface-exposed residues show signatures of positive selection, potentially reflecting adaptations to host immune recognition or environmental pressures. Codon usage analysis reveals optimization toward host-specific tRNA pools in pathogenic subspecies compared to environmental Francisella species, suggesting adaptation for efficient translation during infection. Protein structure prediction models indicate conservation of secondary structure elements despite sequence variations, maintaining the core functional architecture while allowing surface modifications. These evolutionary insights suggest atpF represents a highly constrained component of Francisella's core machinery with subtle adaptations that may contribute to the distinct host ranges and virulence potential of different subspecies.

How can structural modeling help predict functional domains and potential interaction sites of F. tularensis atpF?

Structural modeling provides valuable insights into F. tularensis atpF's functional architecture by predicting critical domains and interaction interfaces that guide experimental design. Using homology modeling based on crystallized ATP synthase structures from E. coli (PDB: 6OQR) and Mycobacterium species as templates, researchers can generate reliable models of atpF's tertiary structure despite moderate sequence identity (30-45%). These models consistently reveal a bipartite organization: an N-terminal membrane-anchoring domain containing two transmembrane α-helices connected by a short periplasmic loop, and a C-terminal cytoplasmic domain comprising a long α-helix that extends into the F₁ sector. Electrostatic surface potential analysis identifies a positively charged patch in the C-terminal region that likely mediates interactions with the negatively charged surfaces of ATP synthase δ and α subunits. Molecular dynamics simulations refine these models by assessing stability in membrane environments and identifying flexible regions. Conservation mapping onto the structural model reveals highly conserved surfaces that correlate with predicted protein-protein interaction interfaces. Coevolutionary analysis using methods like GREMLIN identifies residue pairs that have evolved in tandem, further supporting predicted interaction networks. These structural predictions guide targeted mutagenesis experiments for functional validation and provide a rational framework for designing peptide inhibitors or antibodies targeting atpF. The integration of structural modeling with evolutionary analysis creates a powerful platform for understanding structure-function relationships in this important membrane protein.

How can recombinant F. tularensis atpF be utilized in vaccine development strategies?

Recombinant F. tularensis atpF offers several promising avenues for tularemia vaccine development, leveraging both its membrane localization and essential role in bacterial metabolism. As a membrane-associated protein with exposed epitopes, atpF can serve as an antigen component in subunit vaccines when combined with appropriate adjuvants. Protein engineering approaches have enabled the development of chimeric constructs where immunodominant epitopes from other Francisella antigens are fused to atpF, creating multivalent antigens that stimulate broader immune responses. Liposome-based delivery systems incorporating purified recombinant atpF have demonstrated enhanced immunogenicity compared to soluble protein formulations, likely due to mimicry of bacterial membrane presentation. When used in immunization studies, atpF-containing vaccines elicit both humoral and cell-mediated immune responses, with antibodies recognizing native protein on the bacterial surface and T-cell responses targeting processed peptides. The essential nature of atpF for bacterial viability means that antibodies or immune cells targeting this protein may effectively neutralize the pathogen. Importantly, the high conservation of atpF across Francisella subspecies suggests that vaccines based on this protein could provide cross-protection against multiple strains. Current research is focused on optimizing antigen presentation, adjuvant formulations, and delivery platforms to maximize protective efficacy while maintaining safety profiles suitable for human use .

What role might atpF play in antimicrobial resistance mechanisms in F. tularensis?

Although F. tularensis does not exhibit widespread antimicrobial resistance compared to many other bacterial pathogens, emerging evidence suggests atpF may contribute to intrinsic resistance mechanisms through both direct and indirect pathways. ATP synthase inhibition represents a collateral damage mechanism for certain antibiotics, and mutations in atpF that modify inhibitor binding sites could potentially confer resistance to such compounds. More significantly, the bioenergetic function of atpF indirectly impacts susceptibility to multiple antibiotic classes through several mechanisms. First, energy-dependent efflux pumps require ATP generated by ATP synthase to extrude antibiotics from the bacterial cell; thus, alterations in atpF that enhance ATP production could increase efflux capacity. Second, decreased membrane potential resulting from ATP synthase perturbations affects uptake of aminoglycosides and certain other antibiotics that require proton-motive force for entry. Third, ATP availability influences stress response pathways and general metabolic state, potentially affecting bacterial persistence during antibiotic exposure. Experimental evidence demonstrates that F. tularensis strains with specific atpF variants show altered susceptibility profiles to antibiotics like doxycycline and gentamicin despite these drugs not directly targeting ATP synthase. Proteomics studies reveal that antibiotic exposure triggers changes in atpF expression levels, suggesting regulatory adaptations to maintain energy homeostasis during stress. These findings highlight the complex role of bioenergetics in antibiotic responses and suggest that targeting atpF could potentially enhance the efficacy of existing antimicrobials against F. tularensis .

How can cryo-EM techniques be applied to study the structure of F. tularensis ATP synthase complexes containing atpF?

Cryo-electron microscopy (cryo-EM) represents a revolutionary approach for studying the structure of F. tularensis ATP synthase complexes containing atpF, overcoming limitations of traditional crystallographic methods for membrane protein complexes. The workflow begins with isolation of intact ATP synthase complexes either from native F. tularensis membranes or reconstituted from recombinant components, maintaining native lipid interactions through detergent solubilization or nanodisc incorporation. Sample preparation requires optimization of concentration (typically 1-3 mg/ml), detergent type and concentration, and buffer components to prevent aggregation and promote random particle orientation on cryo-EM grids. Data collection employs direct electron detectors with motion correction and automated acquisition software to collect thousands of micrographs containing particles in diverse orientations. Image processing follows established workflows using software packages like RELION or cryoSPARC, involving particle picking, 2D classification, ab initio model generation, and 3D refinement to achieve high-resolution reconstructions. Current technology can potentially achieve sub-3Å resolution for well-behaved samples, revealing detailed interactions between atpF and other subunits within the complete complex. Particular attention should focus on the membrane-embedded region where atpF anchors, often challenging to resolve due to detergent or nanodisc interference. Complementary approaches like crosslinking mass spectrometry (XL-MS) provide distance constraints that enhance model building in regions of lower local resolution. This structural information can reveal unique features of F. tularensis ATP synthase architecture and identify potential species-specific targeting sites for therapeutic development.

What are common challenges in expressing recombinant F. tularensis atpF and how can they be overcome?

Researchers frequently encounter several challenges when expressing recombinant F. tularensis atpF, each requiring specific mitigation strategies. The most common issue is protein misfolding and aggregation due to hydrophobic transmembrane regions, which can be addressed by using specialized E. coli strains like C41(DE3) or Lemo21(DE3) designed for membrane protein expression, combined with reduced expression temperatures (16-20°C) and lower inducer concentrations. Toxicity to host cells often occurs when atpF insertion disrupts membrane integrity; this can be mitigated using tightly controlled expression systems with glucose repression to prevent leaky expression and gradually adapting cells with very low inducer concentrations. Poor yield is frequently reported and can be improved by optimizing codon usage for the expression host, adding fusion partners like MBP or SUMO that enhance solubility, and screening multiple constructs with varying N-terminal and C-terminal boundaries. Proteolytic degradation can be reduced by incorporating protease inhibitor cocktails throughout purification and minimizing sample handling time and temperature. For membrane incorporation issues, supplementing media with phospholipid precursors and optimizing membrane fraction isolation protocols can improve proper insertion. When protein appears properly expressed but lacks function, careful attention to detergent selection during purification and reconstitution into native-like lipid environments may restore activity. A systematic approach addressing these challenges sequentially, combined with rigorous quality control at each step, significantly improves success rates for obtaining functional recombinant atpF.

How can researchers validate antibody specificity for F. tularensis atpF in immunological studies?

Validating antibody specificity for F. tularensis atpF requires a comprehensive approach combining multiple complementary techniques to ensure reliable immunological study results. The gold standard validation begins with western blot analysis comparing wild-type F. tularensis lysates with those from atpF deletion mutants (ΔatpF) and complemented strains, expecting signal only in samples containing the target protein. Preabsorption controls where antibodies are pre-incubated with purified recombinant atpF before immunodetection should eliminate specific signals. For immunofluorescence microscopy validation, parallel staining of wild-type and ΔatpF strains should show differential labeling patterns consistent with membrane localization in wild-type cells only. Epitope mapping using synthetic peptides or truncated recombinant constructs can identify the specific regions recognized by antibodies, helping predict potential cross-reactivity. Cross-reactivity assessment should include western blots against closely related bacterial species and isolated membrane proteins of similar molecular weight. For polyclonal antibodies, affinity purification against immobilized recombinant atpF significantly improves specificity. Quantitative validation metrics should include signal-to-noise ratios, coefficients of variation across replicates, and detection limits established using known quantities of recombinant protein. Additional validation through immunoprecipitation followed by mass spectrometry identification provides definitive confirmation of antibody target specificity. These rigorous validation approaches ensure that subsequent immunological studies accurately reflect atpF biology rather than artifacts from cross-reactive antibodies.

What strategies can address difficulties in developing F. tularensis atpF knock-out mutants for functional studies?

Creating F. tularensis atpF knock-out mutants presents significant challenges due to the gene's essential nature, requiring specialized strategies to study its function. Conditional mutation approaches offer the most viable solution, beginning with the construction of merodiploid strains containing both the chromosomal atpF and an inducible copy integrated elsewhere or on a plasmid. This permits subsequent deletion of the chromosomal copy while maintaining viability through expression of the inducible gene. Inducible promoter systems using tetracycline-responsive elements or arabinose-inducible promoters allow titration of expression levels for studying partial loss-of-function. For complete deletion studies, metabolic bypasses must be engineered, such as introducing alternative ATP-generating systems or growing bacteria on fermentable carbon sources that reduce dependence on oxidative phosphorylation. Domain-specific deletion constructs that maintain essential functions while disrupting specific protein interactions can reveal nuanced functional roles. CRISPR interference (CRISPRi) using catalytically dead Cas9 provides an alternative approach for tunable, reversible repression of atpF expression without genetic deletion. Transposon mutant libraries with insertions in non-essential regions of atpF can identify functional domains through partial disruption. Chemical genetic approaches using specific ATP synthase inhibitors at sub-lethal concentrations can complement genetic approaches. These strategies should be validated by measuring ATP production, membrane potential, and growth rates across varying conditions to confirm the functional consequences of atpF perturbation and develop appropriate experimental conditions for subsequent pathogenesis studies.

What are the most promising future research directions for F. tularensis atpF studies?

The most promising future research directions for F. tularensis atpF studies span multiple dimensions of microbiology, from fundamental mechanisms to translational applications. High-resolution structural determination of the complete F. tularensis ATP synthase complex through cryo-EM represents a critical next step, potentially revealing unique features that distinguish it from model bacterial systems. Comprehensive interactome mapping using proximity labeling approaches may uncover unexpected non-canonical interactions of atpF with virulence-associated proteins, potentially revealing moonlighting functions. Systems biology approaches integrating transcriptomics, proteomics, and metabolomics data from atpF-modulated strains could elucidate the broader metabolic consequences of ATP synthase perturbation during infection. Development of small molecule inhibitors specifically targeting F. tularensis atpF through structure-based drug design offers potential therapeutic applications, particularly if species-specific binding pockets can be identified. The role of atpF in bacterial adaptation to host microenvironments during different infection stages represents another promising area, potentially explaining how F. tularensis modulates its bioenergetics during phagosomal escape and cytosolic replication. Immunological studies examining the potential of atpF as a vaccine antigen component and the role of anti-atpF antibodies in protective immunity would advance translational applications. Single-cell approaches tracking ATP synthase activity during infection could reveal heterogeneity in bacterial metabolic states and identify subpopulations with altered susceptibility to antibiotics or host defenses. These diverse research directions collectively promise to transform our understanding of this essential component of bacterial bioenergetics and its connections to pathogenesis.

How might advances in structural biology techniques influence our understanding of F. tularensis atpF function and interactions?

Recent advances in structural biology techniques are poised to revolutionize our understanding of F. tularensis atpF through unprecedented visualization of its molecular architecture and dynamic interactions. Cryo-electron tomography (cryo-ET) now enables visualization of ATP synthase complexes directly within bacterial membranes, potentially revealing native organization and stoichiometry specific to F. tularensis without extraction or reconstitution artifacts. Advanced cryo-EM methods including time-resolved cryo-EM and researchers' ability to capture different conformational states during the catalytic cycle could elucidate the dynamic contributions of atpF to rotational mechanics and proton translocation. Integrative structural biology approaches combining cryo-EM with mass spectrometry, molecular dynamics simulations, and crosslinking studies can generate comprehensive models of atpF's interactions within the complete ATP synthase complex. Single-molecule Förster resonance energy transfer (smFRET) techniques applied to reconstituted systems could measure conformational changes in atpF during ATP synthesis and hydrolysis, providing dynamic information inaccessible to static structural methods. Hydrogen-deuterium exchange mass spectrometry (HDX-MS) can map protein flexibility and solvent accessibility, identifying regions of atpF that undergo conformational changes upon interaction with other subunits or under different physiological conditions. The application of AlphaFold2 and other AI-based structure prediction tools, especially when combined with sparse experimental constraints, may accelerate structural characterization of atpF variants or complexes not amenable to traditional structural determination. These technical advances collectively promise to transform atpF from a genetically and biochemically characterized component to a dynamically understood molecular machine in the context of F. tularensis pathogenesis.